Gooch & Housego (GHH) Q2 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 TU earnings summary
9 Apr, 2026Executive summary
Revenue for H1 2026 reached £81.9 million, up 9.1% year-over-year on an organic, constant currency basis.
Strong demand from Aerospace and Defence markets, with industrial laser and semiconductor markets showing recovery.
Order book increased to £167.3 million as of 31 March 2026, a 16.5% rise from 30 September 2025 on a constant currency basis.
Integration of recent acquisitions (Global Photonics and Phoenix Optical) progressing as planned, supporting new defence orders.
Appointment of new CFO, James Corte, with experience in industrial and defence sectors.
Financial highlights
H1 2026 revenue: £81.9 million (H1 2025: £70.8 million), a 9.1% organic, constant currency increase.
Net debt (excluding lease liabilities) at 31 March 2026: £37.0 million (31 March 2025: £24.1 million; 30 September 2025: £29.9 million).
£15.7 million available for future growth activities.
Outlook and guidance
Trading for FY 2026 expected to be in line with management's expectations.
Sustained recovery anticipated in industrial laser and semiconductor markets.
Strong growth in Aerospace and Defence demand expected to continue.
Targeting mid-teens returns over the medium term.
Latest events from Gooch & Housego
- Revenue up, profit down; strong order book and A&D/Life Sciences offset industrial weakness.GHH
H2 202411 Mar 2026 - Revenue and profit fell, but improved margins and a strong order book support a positive outlook.GHH
H1 202411 Mar 2026 - Acquisition creates a U.S. optical systems hub, boosting defense capabilities and growth potential.GHH
M&A announcement11 Mar 2026 - Revenue and profit surged, led by A&D and Life Sciences, with strong order cover for FY2025.GHH
H1 202511 Mar 2026 - Double-digit revenue and profit growth driven by A&D and acquisitions, with a record order book.GHH
H2 202511 Mar 2026 - Solid FY2024 results and acquisitions set the stage for growth in Life Sciences and Defence.GHH
Investor presentation11 Mar 2026 - Order book grew to £126.4M, driven by innovation, acquisitions, and operational improvements.GHH
AGM 2025 presentation11 Mar 2026 - Double-digit revenue growth and record order intake driven by A&D and new technology focus.GHH
AGM 2026 presentation11 Mar 2026 - Revenue delays impact FY2024, but strategic progress and FY2025 outlook remain strong.GHH
Trading update11 Mar 2026